
Dr. Elizabeth Rebello
Dr. Elizabeth Rebello is a representative from the University of Texas MD Anderson Cancer Center, who voiced concerns during the FDA advisory committee meetings about the lack of scientific evidence supporting the safety and efficacy of the proposed peptides for compounding.
Power12,167
Reach191,774
Country presence
Recent news mentions
Dr. Elizabeth Rebello is affiliated with the University of Texas MD Anderson Cancer Center.
FDA advisers support easing restrictions on six peptides. Here’s what those drugs are and what happens nextCNN·
United States· 2026-07-31





